Close Menu

NEW YORK – Amazon said Friday it is investing an initial $20 million through its AWS Diagnostic Development Initiative to accelerate diagnostic research, innovation, and development that speeds understanding and detection of the coronavirus that causes COVID-19.

The company said in its Dayone blog that the initiative will be open to accredited research institutions and private entities that are using Amazon Web Services to support research-oriented workloads for the development of point-of-care testing that can be done at home or at a clinic with same-day results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.